US Broker Ratings

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Unveiling a 40% Upside Potential in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is currently capturing the attention of investors with its promising outlook and significant upside potential. With a market..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Analysts Forecast a 41.83% Upside Amid Healthcare Sector Challenges

Brookdale Senior Living Inc. (NYSE: BKD), a key player in the healthcare sector, particularly within the medical care facilities industry, is capturing investor interest with a notable potential upside of..

Immunovant, Inc. (IMVT) Stock Analysis: Assessing the 21% Potential Upside with Strong Analyst Confidence

Immunovant, Inc. (NASDAQ: IMVT), a burgeoning force within the biotechnology sector, is capturing attention with a notable market cap of $8.24 billion and a unique focus on developing therapies for..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: High ROE and 17.76% Potential Upside Highlight Growth Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), with its focus on the healthcare sector, plays a crucial role in servicing long-term care facilities (LTCFs) across the United States. Headquartered in Atlanta,..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a 35% Upside Potential in the Dynamic Biotech Sector

Investors in the biotechnology sector are no strangers to the allure of high-risk, high-reward opportunities, and Celldex Therapeutics, Inc. (NASDAQ: CLDX) is no exception. With a market capitalization of $3.37..

Haemonetics Corporation (HAE) Stock Analysis: Unveiling 11% Growth Potential Amidst Robust Healthcare Innovations

Haemonetics Corporation (NYSE: HAE), a venerable name in the healthcare sector, is making waves in the medical device industry with its innovative technologies and strategic market positioning. With a market..

Select Medical Holdings Corp. (SEM) Stock Analysis: Navigating the Healthcare Sector with a Stable Outlook

Select Medical Holdings Corporation (NYSE: SEM) operates within the dynamic healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $2.05 billion, SEM is..

Schrodinger, Inc. (SDGR) Stock Analysis: Is There a 9.60% Upside Potential?

Schrodinger, Inc. (NASDAQ: SDGR), a prominent player in the health information services industry, is capturing investor attention with its innovative approach to molecular discovery and drug development. With a market..

Ligand Pharmaceuticals (LGND) Stock Analysis: 16% Upside Potential Amid Strong Buy Ratings

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector with its robust pipeline and a promising upside potential of 16.27%, according to recent analyst ratings. With a market..

Kymera Therapeutics, Inc. (KYMR): Investor Outlook on Promising 20% Upside Potential

For individual investors eyeing the biotechnology sector, Kymera Therapeutics, Inc. (NASDAQ: KYMR) presents an intriguing opportunity. The company, headquartered in Watertown, Massachusetts, is making waves with its cutting-edge approach to..

PACS Group, Inc. (PACS) Investor Outlook: Strong Buy Ratings Signal Potential 22% Upside

PACS Group, Inc. (PACS), a growing player in the healthcare sector, is making waves with its impressive market presence and financial performance. Headquartered in Salt Lake City, Utah, PACS operates..

Addus HomeCare Corporation (ADUS) Stock Analysis: A 12.86% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing prospect. With its unique positioning in the medical care facilities industry, Addus HomeCare is..

PGIM Securitized Income ETF (PINC) Stock Report: Stability in Securitized Credit Investments

For investors seeking stability in the often volatile world of investments, the PGIM Securitized Income ETF (NYSEARCA: PINC) offers a unique proposition. With a substantial market capitalization of $4.13 billion,..

MannKind Corporation (MNKD) Stock Analysis: A 102.77% Potential Upside in the Biotech Arena

MannKind Corporation (MNKD), a pivotal player in the biotechnology sector, is catching the attention of investors with a remarkable potential upside of 102.77%. Specializing in innovative solutions for chronic diseases,..

Clover Health Investments, Corp (CLOV)

⚠️ No article content returned.

..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring the 9.23% Potential Upside in the Booming Medical Devices Sector

For investors seeking exposure to the burgeoning healthcare sector, particularly within the medical devices industry, UFP Technologies, Inc. (NASDAQ: UFPT) presents an intriguing opportunity. With a market capitalization of $2.52..

Organon & Co. (OGN) Stock Analysis: Navigating the Healthcare Sector with Strategic Insights

Investors looking to navigate the complex landscape of healthcare investments might find Organon & Co. (NYSE: OGN) an intriguing prospect. With a market capitalization of $3.58 billion, Organon operates in..

Vera Therapeutics (VERA) Stock Analysis: A Biotech with Potential 157.85% Upside

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company, stands at a pivotal point in its growth trajectory, with analysts projecting a significant potential upside of 157.85%. With its focus..

Liquidia Corporation (LQDA) Stock Analysis: Unpacking Robust Revenue Growth and Strategic Positioning

Liquidia Corporation (NASDAQ: LQDA), a prominent player in the healthcare sector, is capturing investor attention with its remarkable revenue growth and strategic advancements in treating rare cardiopulmonary diseases. Based in..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a Potential 71% Upside in the Healthcare Sector

HUTCHMED (China) Limited (HCM), a key player in the healthcare sector, is drawing investor attention with its specialization in developing targeted therapeutics and immunotherapies to combat cancer and immunological diseases...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds